Genfit SA (GNFT)
4.21
-0.03
(-0.71%)
USD |
NASDAQ |
Nov 22, 13:16
Genfit Revenue (Quarterly): 15.36M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.36M |
September 30, 2023 | 3.068M |
Date | Value |
---|---|
December 31, 2022 | 6.232M |
September 30, 2022 | 5.349M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.068M
Minimum
Sep 2023
15.36M
Maximum
Dec 2023
7.503M
Average
5.791M
Median
Revenue (Quarterly) Benchmarks
Edap TMS SA | 14.41M |
DBV Technologies SA | -- |
Cellectis SA | 16.20M |
Adaptimmune Therapeutics PLC | 40.90M |
Akari Therapeutics PLC | -- |
Revenue (Quarterly) Related Metrics
Enterprise Value | 212.18M |
Earnings Yield | 2.68% |
Operating Earnings Yield | 5.09% |
Normalized Earnings Yield | 2.500 |